联合举措
主席
希腊雅典Sotiria医院第三医学部雅典大学高血压中心STRIDE-7内科与高血压教授
Secretary, International Society of Hypertension (ISH) Council member. Immediate Past Chairman, European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and Cardiovascular Variability (2016-2022). World Hypertension League (WHL) Special Envoy for BP Measurement. International Pediatric Hypertension Association Executive Committee member. International Standardization Organization committee member on BP monitoring equipment. Elected Fellow Royal College of Physicians, Glasgow, UK. ESH ‘Peter Sleight’ Award for outstanding contribution in research, education, and leadership.
ESH Guidelines writing committee member for BP methodology; Pediatric hypertension; Hypertension Clinic set-up; BP monitors validation. Invited speaker at Hypertension Societies meetings (ESH, ISH, Australian, Belgian, Canadian, Chinese, Danish, German, Indian, Japanese, Korean, Spanish). Past President Hellenic Society of Hypertension. Chaired guidelines for hypertension management and pediatric hypertension. Founded the ‘School of Hypertension’. Assoc Editor: Hyperten Res, J Clin Hyperten. Editorial board member: 11 PubMed journals. Reviewer: 56 PubMed journals; BMJ Publishing Group, McMaster University's Health Information Research; 22 ESH and ISH meetings.
Research work focused on BP monitoring methodology and technology development and validation; pediatric hypertension; hypertension diagnosis; epidemiology; antihypertensive drug action. Authored 370 PubMed articles; Presented >350 papers; Supervised 25 MD theses. h-index 79; Citations 52,000 including citations in Hypertension Societies’ guidelines (ESH, ISH, American, British, Canadian, Australian, Japanese).
联席主席
澳大利亚悉尼新南威尔士大学医学部大众健康系心脏、血管和代谢医学教授兼首席主题组长。澳大利亚悉尼乔治全球健康研究所心血管项目教授级研究员
联席主席
澳大利亚悉尼新南威尔士大学医学部大众健康系心脏、血管和代谢医学教授兼首席主题组长。澳大利亚悉尼乔治全球健康研究所心血管项目教授级研究员
Alta (Aletta E.) is a Strategic Hires (SHARP) Professor of Cardiovascular Medicine at UNSW Sydney with a joint appointment as Professorial Fellow at The George Institute Australia. She also holds a professorial appointment at North-West University and the University of the Witwatersrand, South Africa. She was the President of the International Society of Hypertension (2018-2020), during which time she initiated the development of the 2020 ISH Global Hypertension Practice Guidelines for low and high resource settings.
She a leading researcher in hypertension and cardiovascular health, with a research interest is the early detection, prevention and effective management of hypertension, where she has led many population and clinical studies. She has been the Chief Investigator of several multidisciplinary studies investigating social, environmental and behavioural determinants of raised blood pressure, subsequent organ damage and cardiovascular disease across the life course. Alta is an invited author of the Lancet Commission on Hypertension, and of the World Health Organization’s Technical Specifications Report for Automated Non-Invasive Blood Pressure Measuring Devices 2020. Since 2017 she contributed to the establishment of the May Measurement Month global blood pressure screening campaign through the International Society of Hypertension, and she continues to contribute to the campaign as a Trustee.
She has published over 450 papers in the field, and is involved in numerous international consortia, such as the Global Burden of Disease study and the NCD Risk Factor Collaboration, World Health Organization working groups and the Lancet Commission of Hypertension. Alta is an Associate Editor of Hypertension, and editorial board member of all major hypertension journals.
荣誉主席
爱尔兰都柏林大学学院Conway研究所分子药理学兼任教授
Eoin O’Brien is a former Professor of Molecular Pharmacology at the Conway Institute of Biomolecular and Biomedical Research at University College Dublin, where he led international scientific research into high blood pressure. He has been an advocate of the importance of standardising methods of blood pressure measurement and assessing the accuracy of devices used to measure blood pressure. He has been the lead author of the International Protocols of Hypertension for the validation of blood pressure measuring devices, and he has supported and guided the STRIDE BP initiative to provided users of blood pressure measuring devices with regular lists of accurate information on the most accurate and reliable devices on the market. He has written extensively on the technique of ambulatory blood monitoring as the method of choice for out-of-office measurement in patients with hypertension. He has served in an administrative capacity on several national and international bodies concerned with the global management of cardiovascular disease.
Eoin O’Brien was awarded the Robert Tigerstedt Lifetime Achievement Award for 2022 by the International Society of Hypertension in October 2022 at the Scientific Meeting of the Society in Kyoto, Japan. He is the first Irish doctor to be honoured with this award, which he accepted on behalf of his Irish and international colleagues.
In addition to his scientific writing, he has written books on the history of medicine, and on Dublin writers and artists including an acclaimed biographical study on Samuel Beckett, who was his friend for many years. The Weight of Compassion & Other Essays was published by Lilliput Press in 2012 and his latest book, co-edited with Professor Gerald Dawe, The poems of Ethna MacCarthy, was published by Lilliput Press in September 2019. His memoir A Life in Medicine: From Aesculapius to Beckett will be published by Lilliput Press in early 2023.
加拿大多伦多大学荣誉教授，多伦多新宁健康科学中心心脏病专科名誉顾问。
加拿大多伦多大学荣誉教授，多伦多新宁健康科学中心心脏病专科名誉顾问。
Dr. Myers received his medical degree from the University of Toronto and completed postgraduate training in Internal Medicine and Cardiology in Toronto. He developed an interest in hypertension during a research fellowship in Clinical Pharmacology at the Hammersmith Hospital in London, UK. Dr. Myers has been active in hypertension at both the national and international level. He conceived the Canadian Hypertension Society in 1977 and has been a member of the International Society of Hypertension since 1978. He has been an active participant in the ESH Working Group on BP Monitoring for over 30 years.
In the last two decades his research interests have encompassed a wide range of topics in both hypertension and cardiology. He was among the first to describe the dose-response characteristics of antihypertensive drugs. He introduced 24-hour ambulatory BP monitoring into Canada in 1985 and in 1991 proposed the concept of white coat effect to describe office-induced hypertension in treated patients. In the last decade, his main research interest has been blood pressure measurement, especially the development of automated office BP a replacement for manual BP measurement in clinical practice. His research has led to the introduction of automated office blood pressure measurement as the preferred technique in Canadian and American hypertension guidelines.
意大利帕多瓦大学内科学教授，现职：意大利帕多瓦大学Patavinum研究院高级学者
Medical education and current positions: Medical education at the University of Padova, Italy. Worked for 5 years at the Laboratory of Professor Stevo Julius at the University of Michigan (USA). Past Professor of Internal Medicine and Chair of the Vascular Medicine Unit at the University of Padova, Padua, Italy.
Areas of research: Pathophysiology of the autonomic nervous system, genetics of hypertension and cardiovascular disease, pathophysiology of renal hemodynamics in hypertension and myocardial infarction, clinical epidemiology, exercise hemodynamics, and blood pressure measurement techniques.
Awards and publications: Past Secretary of the Italian Hypertension League and Member of the Boards of the Italian Society of Hypertension, Italian Society of Sports Cardiology, and the Italian Society of Nephrocardiology. Deputy Chairman of the Working Group on ABPM and BP Variability of the European Society of Hypertension. Coordinator of the HARVEST Study. Coordinator of several international and national studies of hypertension and of clinical pharmacology. Received the local Honour at the University of Michigan (USA). Member of the Editorial Board of several International Journals including Hypertension and the Journal of Hypertension. Published over 500 original articles and reviews in international journals for a global IF >2400. Present H-index = 75 with 26,000 citations according to Google Scholar.
心血管内科教授
中国上海市上海交通大学医学院
Ji-Guang Wang is director of the Shanghai Institute of Hypertension, and director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
At present, he is coordinating several multicentre randomized clinical trials and population- and patient- cohort studies in China. He has published 559 full-length articles on hypertension in the international literature and 193 articles in the Chinese literature, and has lectured extensively in international and China national conferences.
He is a former Executive Council Member of the International Society of Hypertension, past president of he Asian-Pacific Society of Hypertension, past president of the Pulse of Asia Society, current deputy president of the HOPE Asia Network, and current president of the Chinese Hypertension League.
He serves on the editorial board of several international and China national journals in the field of hypertension and cardiovascular medicine as Editor-in-Chief (The Journal of Clinical Hypertension), Associate Editor (Hypertension, Hypertension Research, and so on), Section Editor or a Member.
意大利米兰市Milano-Bicocca大学内科与外科系心血管内科教授，意大利米兰IRCCS Auxologico科学院意大利San Luca医院心血管神经和代谢科科学总监兼主任
意大利米兰市Milano-Bicocca大学内科与外科系心血管内科教授，意大利米兰IRCCS Auxologico科学院意大利San Luca医院心血管神经和代谢科科学总监兼主任
- MD Degree, Specialization in Cardiology and in Internal Medicineat theUniversity of Milan, Italy. Visiting Professor at MassachusettsInstitute of Technology, Boston, USA, and atChildren Hospital Harvard Medical School, Boston & Cambridge,USA.
- ScientificDirectorIstitutoAuxologico Italiano, IRCCS, Milan, Italy. Head, Cardiology Unit and Dept of Cardiovascular, Neural and Metabolic Sciences, St LucaHospital, Istituto Auxologico Italiano,IRCCS, Professor of Cardiovascular Medicine, Dept of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
- Past President,Italian Society of Hypertension.Past Chairmanof ESH Working Groupon Blood Pressure Monitoring and Cardiovascular Variability. Fellow of the European Society of Cardiology. Nucleus Member and Treasurer of the Council on Hypertension of the European Society of Cardiology.Chairman of the Working Group on Blood PressureMonitoring, ItalianSociety of Hypertension.
- Bjorn Folkow 2015 Award as Top European Investigator in Hypertension Pathophysiology.
- Executive Editor of the Journal of Hypertensionand Associate Editor of Hypertension Research.
- Coordinator of a number of international research projects dealing with: Blood Pressure measurement; Blood Pressure Variability;Sleep and Sleep Related BreathingDisorders; Masked Hypertension worldwide (MASTER Study);Cardiovascular Effects of Altitude Exposure (HIGHCARE PROJECTSon Europe Alps, Himalaya and Peruvian Andes); Space research on microgravity (NASA ,ESA); Telemedicine, Digital Health and Mobile Health through development of a validated application for smartphones.
- Publicationsandmetrics: >869publications in peer reviewed Journals and books (IF 1815.6; H. Index 88; Total citations 37,336–from Scopus). Orcid http://orcid.org/0000-0001-9402-7439
爱尔兰都柏林大学学院Conway研究所分子药理学兼任教授
Eoin O’Brien is a former Professor of Molecular Pharmacology at the Conway Institute of Biomolecular and Biomedical Research at University College Dublin, where he led international scientific research into high blood pressure. He has been an advocate of the importance of standardising methods of blood pressure measurement and assessing the accuracy of devices used to measure blood pressure. He has been the lead author of the International Protocols of Hypertension for the validation of blood pressure measuring devices, and he has supported and guided the STRIDE BP initiative to provided users of blood pressure measuring devices with regular lists of accurate information on the most accurate and reliable devices on the market. He has written extensively on the technique of ambulatory blood monitoring as the method of choice for out-of-office measurement in patients with hypertension. He has served in an administrative capacity on several national and international bodies concerned with the global management of cardiovascular disease.
Eoin O’Brien was awarded the Robert Tigerstedt Lifetime Achievement Award for 2022 by the International Society of Hypertension in October 2022 at the Scientific Meeting of the Society in Kyoto, Japan. He is the first Irish doctor to be honoured with this award, which he accepted on behalf of his Irish and international colleagues.
In addition to his scientific writing, he has written books on the history of medicine, and on Dublin writers and artists including an acclaimed biographical study on Samuel Beckett, who was his friend for many years. The Weight of Compassion & Other Essays was published by Lilliput Press in 2012 and his latest book, co-edited with Professor Gerald Dawe, The poems of Ethna MacCarthy, was published by Lilliput Press in September 2019. His memoir A Life in Medicine: From Aesculapius to Beckett will be published by Lilliput Press in early 2023.
日本东京帝京大学医学院卫生与公众健康系教授，比利时鲁汶荷兰语天主教鲁汶大学心血管学系客座教授。
Kei Asayama is a Professor at the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. K Asayama received his MD in 2001 and his PhD in 2005 from Tohoku University, Sendai, Japan. Following his clinical and research activities at the same university, he underwent a fellowship at KU Leuven in Belgium from 2011 to 2014.
K Asayama is a member of several professional societies. He is a council member and fellow of the Japanese Society of Hypertension (JSH), the International Society of Hypertension (ISH) Fellow and the ISH College of Experts, and the Council of the Japanese Society of Cardiovascular Disease Prevention. He is an ISO/TC121 committee member of the Japan Association of Medical Equipment Industries.
The research interests of K Asayama focus on cardiovascular epidemiology, particularly hypertension. He is a project manager of the multicenter HOMED-BP (Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure) study, and a core member of the Ohasama cohort study. He contributes to individual participant-data meta-analyses on IDACO (International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcome) and IDHOCO (International Database of HOme blood pressure in relation to Cardiovascular Outcome).
瑞士日内瓦医学研究所基金会(F-MRI®)主席，黎巴嫩大学临床研究教育负责人
Prior to this position, past-President of the “Cardiovascular Institute”, Paris, France., Professor of Therapy and previous president of the Working Group ‘Measurement and Evaluation’ of the French Society of Hypertension. Past president of the International Society of Vascular Health (ISVH) and previous chairman of the working group on blood pressure measurements of the European Society of Hypertension. Dr Asmar received the distinction ‘Cardiologist of the Year 2001 in France for his Continuous Medical Education activity.
Member of several international committees and scientific societies, Editor in chief of the “Vascular health and Risk management” journal. Dr Asmar has published more than 250 scientific articles and several books. Being lead member in the organization of several international Consensus Conferences and participant in several guidelines. Inventor of patented & marketed devices for BP measurement & arterial assessment. Research interests include hypertension, blood pressure measurements, non-invasive evaluation of arterial stiffness, hemodynamic and atherosclerosis.
澳大利亚悉尼麦考瑞大学医学、健康和人文科学学院医学系荣誉教授
Alberto Avolio is Professor Emeritus in the Faculty of Medicine, Health and Human Sciences at Macquarie. He graduated in Electrical Engineering, BE and PhD (Biomedical) from the University of New South Wales, Sydney, and spent a post-doctoral period in the Department of Physiology at the University of Leiden, The Netherlands.
He has been involved in teaching and research in biomedical sciences and engineering and in applications of cardiovascular dynamics. He is Fellow of the International Academy of Medical and Biological Engineering (FIAMBE), and Fellow of the Institution of Electrical and Electronic Engineering (FIEEE). Research fields include pulsatile relationships of blood pressure and flow, non-invasive assessment of vascular function, measurement of blood pressure, cardiovascular modelling and biological signal processing.
His early studies of age-related changes in blood pressure and stiffness of large arteries in two populations in China with different salt consumption were among the first to highlight the importance of vascular aging and cardiovascular risk. His work on pulse wave analysis formed the background for development of the first devices for noninvasive estimation of central aortic pressure. He is actively involved in research and development of standards for cuffless measurement of blood pressure.
He has published over 300 peer-reviewed journal articles, a book and 17 book chapters with h index: 52 (Scopus); 64 (Google Scholar).
Milano-Bicocca大学内科与外科系副教授，意大利IRCCS Auxologico科学院心脏内科
Milano-Bicocca大学内科与外科系副教授，意大利IRCCS Auxologico科学院心脏内科
Curriculum Vitae
Grzegorz Bilo is a specialist in internal medicine and Associate Professor in the Department of Medicine and Surgery of the University of Milano-Bicocca in Milan, Italy. Since 2018 he coordinates the activities of Hypertension Centre in San Luca Hospital, Istituto Auxologico Italiano, Milan, Italy. Scientific interests focus principally on blood pressure measurement and monitoring, blood pressure variability, cardiovascular pathophysiology and cardiovascular effects of high-altitude hypoxia. He participated in several international research projects on hypertension, was involved in studies on blood pressure measuring devices as well as in the organization of HIGHCARE high-altitude projects.
Dr Bilo is a member of the European Society of Hypertension (ESH) and of the Italian Society of Hypertension (ESH) and participates in the works of the ESH Working Group on Blood Pressure Monitoring and Cardiovascular Variability. He co-authored over 100 research papers (including recommendation documents on home and ambulatory blood pressure monitoring) and several book chapters.
西班牙巴塞罗那大学，Mutua Terrassa医院医学教授、内科主任
西班牙巴塞罗那大学，Mutua Terrassa医院医学教授、内科主任
Alejandro de la Sierra is the Chairman of the Department of Medicine at the Hospital Mutua de Terrassa, Barcelona, Spain. He also serves as Professor of Medicine at the University of Barcelona, Spain. Dr de la Sierra’s main areas of interest are hypertension and cardiovascular prevention. He has published more than 150 original papers in international peer-reviewed publications, as well as editorials, reviews and commentaries and has contributed to National and International Meetings on Hypertension and Cardiology with communications, lectures and chairmanship.
Dr de la Sierra received the Clinical Hypertension Specialist accreditation from the European Society of Hypertension (ESH) in 2001. He is a member of several scientific societies, including the International Society of Hypertension (ISH), the ESH, fellow of the European Society of Cardiology and the American Heart Association, and past-president of the Catalan Society of Hypertension.
荷兰马斯特里赫特市马斯特里赫特大学医学中心医学系内科荣誉退休教授
Professor Peter de Leeuw is emeritus professor of medicine at the Maastricht University Medical Center, Maastricht,The Netherlands. He studied medicine at the Erasmus University in Rotterdam and completed his training in Internal Medicine with professor Birkenhäger at the Zuiderziekenhuis in Rotterdam. After having obtained his PhD in Medicine, he worked as a post-doc research fellow with professor Hollenberg in the Peter Bent Brigham Hospital/Harvard Medical School. Since 1991 he has been professor of Medicine at the University of Maastricht.
Peter de Leeuw was President of the Dutch Society of Hypertension (1988-1996) and has served as a member of the Scientific Council of the International Society of Hypertension (1992-2000). He was and is on the Editorial Board of several journals in the field of hypertension and (general) internal medicine. He has been Editor-inChief of the Netherlands Journal of Medicine (1985-1995), The European Journal of Medicine (2003-2005) and the Nederlands Tijdschrift voor Geneeskunde (Dutch Medical Journal, 2008-2015).
He has been the author or co-author of more than 600 peer-reviewed papers and has contributed to several textbooks. In 2001, he was awarded the RD Wright Lectureship of the High Blood Pressure Research Council of Australia for his work on the kidney. In 2011 he received the Bjorn Folkow Award of the European Society of Hypertension and in 2012 the Birkenhäger Award of the Dutch Hypertension Society.
爱尔兰都柏林Connolly医院中风和高血压科
Dr Dolan is a stroke physician and geriatrician. His research interests include cardiovascular epidemiology, blood pressure monitoring, arterial stiffness, resistant hypertension and stroke. Dr Dolan completed his research thesis with Professor Eoin O'Brien. This fruitful collaboration has allowed Dr Dolan to develop an international profile in hypertension research.
In 2006 Dr Dolan took up a Fellowship in Stroke Medicine at Addenbrooke's Hospital, Cambridge, and was appointed consultant there in 2007. He returned to Connolly Hospital, Dublin, Ireland in April 2009. Dr Dolan was an investigator on an number if studies including the Dublin Outcome Study (DOS), ASCOT ABPM, IDACO,ROX Control HTN and APOLO studies. He has published over 100 peer review papers in the areas of hypertension and stroke. He is a current board member on various national, international and journal advisory boards related to the area of hypertension.
Baker心脏和糖尿病研究所神经药理学实验室主任，NHMRC首席研究员，澳大利亚墨尔本市Monash大学Baker IDI心脏和糖尿病研究所兼任教授
Baker心脏和糖尿病研究所神经药理学实验室主任，NHMRC首席研究员，澳大利亚墨尔本市Monash大学Baker IDI心脏和糖尿病研究所兼任教授
Professor Head is a Principal Research Fellow of the NH&MRC, the Head of the Neuropharmacology Laboratory at the Baker Heart and Diabetes Institute and adjunct Professor at Monash University. He received his B.Sc.(Hons) in Pharmacology from University of Melbourne, Australia in 1976 and Ph.D. from Monash University in 1981. Geoff’s research interests include, the understanding of mechanisms involved in the control of the heart and circulation by the central nervous system and its role in hypertension, heart failure and obesity. In 2014 he was awarded the inaugural Paul Korner prize for research excellence in the field of Neuroscience and hypertension from the International Society of Hypertension and in 2016 awarded the Gaston Bauer prize by the Cardiac Society of Australia and New Zealand.
He is head of the Ambulatory Working group of the High Blood Pressure Research Council of Australia (HBPRCA), chair of the Ambulatory Blood pressure Guidelines joint working party of the National Heart Foundation and the HBPRCA and head of the Australian Ambulatory Blood Pressure Collaborative (AABPMC). He has published 297 scientific papers during his scientific career and holds a patent for a novel therapy for heart failure. He is editor in chief of “Frontiers in Integrative Physiology”. He was Secretary of the High Blood Pressure Research Council of Australia from 2005-10, executive member 2013-2015 and treasurer 2016-2019. Geoff is chair of the Victorian Obesity consortium.
日本仙台东北大学名誉退休教授兼东北血压管理研究所理事会主席
Dr. Yutaka Imai is Professor Emeritus, Tohoku University and Chairman of Trustees, Tohoku Institute for Management of Blood Pressure, Sendai, Japan. Professor Imai was awarded several prizes for his long-time contribution to cardiovascular disease prevention, specifically from the 30-years Ohasama Study, HOMED-BP Study, and J-HOME Study.
Professor Imai was an editorial member of international journals on cardiovascular disease over a long period, such as Journal of Hypertension, Journal of Human Hypertension, Hypertension Research, Clinical Experimental Hypertension, Clinical Experimental Pharmacology Physiology, Blood Pressure Monitoring, and so on. He has published more than 300 peer reviewed English language papers.
塞浦路斯欧洲大学医学院讲师，塞浦路斯美国心脏研究所美国医学中心心脏病专家
Lecturer, School of Medicine, European University Cyprus, Nicosia, Cyprus. Cardiologist, American Medical Center, American Heart Institute, Cyprus. President of the Working Group for Cardiovascular Prevention and Rehabilitation of the Cyprus Society of Cardiology. Reviewer of the 2018 European Society of Cardiology / European Society of Hypertension Guidelines for the management of arterial hypertension, on behalf of the Cyprus Society of Cardiology.
Research focused on blood pressure measurement methods and techniques, automated blood pressure measuring devices technology development and validation, paediatric hypertension. Authored 24 PubMed papers, >1200 citations, h-index: 15
Jichi医科大学医学院(JMU)医学系心血管内科教授，JMU心血管研发卓越中心(JCARD)主任
日本亚洲高血压心血管结局预防和证据网络(HOPE Asia)
Jichi医科大学医学院(JMU)医学系心血管内科教授，JMU心血管研发卓越中心(JCARD)主任
日本亚洲高血压心血管结局预防和证据网络(HOPE Asia)
Dr. Kazuomi Kario graduated from Jichi Medical School in 1986. He is currently Professor and Chairman of Cardiovascular Medicine, Jichi Medical University School of Medicine, Japan. In 2003, Dr Kario and his team were the first to demonstrate ’morning surge’ in blood pressure (BP) as an independent risk factor for cardiovascular disease (Kario et al. Circulation 2003). He first used ’morning hypertension’ with the definition of morning BP ≥135/85 mmHg, regardless of clinic BP. He is the principal investigator of several clinical studies, such as the Japan Morning Surge-Home Blood Pressure (J-HOP);
Japan Ambulatory BP Monitoring (JAMP); Home-activity ICT-based Japan Ambulatory Blood Pressure Monitoring Prospective (HI-JAMP); Sleep BP and disordered breathing in REsistant hypertension And cardiovascular Disease (SPREAD). He is serving as Editor-in-Chief of Hypertension Research and Current Hypertension Reviews. He is an editorial board member of more than 15 international journals including Hypertension, Journal of Hypertension. Professor Kario has published more than 1000 academic papers during his distinguished career. He founded the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia Network)” in 2018.
希腊雅典Sotiria医院第三大学医学系高血压中心STRIDE-7医学教授
European Society of Hypertension Clinical Hypertension Specialist. Specialization in Internal Medicine: Third University Department of Medicine, Sotiria Hospital, Athens, Greece. Doctoral Thesis (PhD): School of Medicine, University of Athens, Greece.
Postgraduate Foreign Clinical Research Fellowship: Dept. of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Istituto Auxologico Italiano & University of Milano-Bicocca, Italy.
Research interests: Blood pressure measurement methodology; development and evaluation of blood pressure measurement technology; blood pressure variability; evaluation of preclinical cardiovascular target organ damage; pediatric hypertension. 161 PubMed publications; 6,900 citations; h-index 41; 4 Scholarships in Medicine; 8 Clinical Research awards.
雅典大学医学院副教授，希腊雅典Alexandra医院临床治疗科
Dr Manios is a hypertension specialist trained in Stroke Medicine at the Stroke Unit, Department of Cardiovascular Sciences, University of Leicester, General Hospital of Leicester in UK. He has over 20 years of experience in Stroke Medicine being an active member of the multidisciplinary stroke team at the Department of Clinical Therapeutics (Acute Stroke Unit, outpatient clinics). Currently Dr Manios serves as the Head of the Hypertension Unit at the Department of Clinical Therapeutics in Athens, Greece (Center of Excellence ESH). He is Secretary of the ESH Working Group on Hypertension and the Brain, member of the ESH Working Group on Blood Pressure Monitoring and Cardiovascular Variability, and member of the Hellenic Society of Hypertension, Hellenic Stroke Organization and European Society of Hypertension.
He is author of more than 130 papers in peer-review international journals and invited speaker in more than 150 invited lectures at national and international meetings. He has participated as co-investigator and principal investigator in several randomized clinical trials in stroke and hypertension. His main research interest focuses on blood pressure measurements, blood pressure variability, blood pressure management in acute stroke and secondary stroke prevention.
澳大利亚悉尼麦格里大学医学与健康科学系名誉高级讲师，悉尼北部地方卫生区皇家北岸医院心内科高级医院科学家
澳大利亚悉尼麦格里大学医学与健康科学系名誉高级讲师，悉尼北部地方卫生区皇家北岸医院心内科高级医院科学家
Anastasia is a Senior Hospital Scientist, who runs the Diagnostic Ambulatory Blood Pressure Monitoring (ABPM) Clinical Service at Royal North Shore Hospital and engages in both biomedical and clinical research as Head of the Cardiovascular & Hormonal Research Laboratory, Kolling Institute and Honorary Senior Lecturer, Macquarie University. Her passion is accuracy of blood pressure measurement for self-management and prevention of hypertension and sex differences in heart disease.
Anastasia has made a significant contribution both to her clinical and biomedical research field, recognized by the American Heart Association by appointing her as AHA Fellow in 2012 and recently Fellow of the Cardiac Society of Australia and New Zealand. Recognition of her contribution to the hypertension field is her appointment on the Advisory Board of the STRIDE_BP to standardize blood pressure measurement and recently on the European Society of Cardiology of Hypertension Committee. Her expertise in the hypertension filed was recognized by Journal of American College of Cardiology (JACC) Case Reports Journal appointing her as Editorial Consultant: Hypertension. The most recent invitations are US Cardiology Review Section Editor for Cardiovascular Disease in Women and The Lancet appointing her to serve as one of the Commissioners for their Commission on Cardiovascular Disease in Women. Anastasia is currently the HBPRCA Executive Member responsible for Education Portfolio and Vice-Chair of the International Society of Hypertension (ISH) Communications Committee.
英国纽卡斯尔大学医学院心血管物理学教授和工程学院教授
英国纽卡斯尔大学医学院心血管物理学教授和工程学院教授
Alan Murray gained his Engineering degree from Strathclyde University, Glasgow, and his PhD from Edinburgh University. He was appointed to Edinburgh University and the Royal Infirmary of Edinburgh, before moving to Newcastle where he was Clinical Director of Physics and Engineering services for 11 hospitals in the north of England.
He gained awards for Innovative Technology and Device Exploitation, Healthcare Scientist of the Year, Honorary Life Member of the International Federation of Medical and Biological Engineering, and the Achievement Medal of The Institution of Engineering and Technology.
He has published over 300 research papers, including in Nature and Lancet. His primary research is in the development of clinical devices and measurement techniques, including blood pressure. He has collaborated and published with colleagues in Scotland, Ireland, Germany, France, Spain, Netherlands, Sweden, Italy, Poland, Australia, USA, China, Brazil, Chile, India, Pakistan, Israel, Libya, Tanzania and Mauritius.
He edited Clinical Physics & Physiological Measurement, Medical & Biological Engineering & Computing, and Computing in Cardiology. He co-authored “Medical Devices: Use and Safety”, which was republished in India for Asia, in Mandarin for China and Farsi for Iran.
加拿大多伦多大学荣誉教授，多伦多新宁健康科学中心心脏病专科名誉顾问。
加拿大多伦多大学荣誉教授，多伦多新宁健康科学中心心脏病专科名誉顾问。
Dr. Myers received his medical degree from the University of Toronto and completed postgraduate training in Internal Medicine and Cardiology in Toronto. He developed an interest in hypertension during a research fellowship in Clinical Pharmacology at the Hammersmith Hospital in London, UK. Dr. Myers has been active in hypertension at both the national and international level. He conceived the Canadian Hypertension Society in 1977 and has been a member of the International Society of Hypertension since 1978. He has been an active participant in the ESH Working Group on BP Monitoring for over 30 years.
In the last two decades his research interests have encompassed a wide range of topics in both hypertension and cardiology. He was among the first to describe the dose-response characteristics of antihypertensive drugs. He introduced 24-hour ambulatory BP monitoring into Canada in 1985 and in 1991 proposed the concept of white coat effect to describe office-induced hypertension in treated patients. In the last decade, his main research interest has been blood pressure measurement, especially the development of automated office BP a replacement for manual BP measurement in clinical practice. His research has led to the introduction of automated office blood pressure measurement as the preferred technique in Canadian and American hypertension guidelines.
日本帝京大学医学院卫生学与公共卫生系教授兼主任
Professor and Chair, Teikyo University School of Medicine (2013); Associate Professor, Shiga University of Medical Science (2010-2013); Assistant or Associate Professor, Tohoku University School of Medicine and Pharmaceutical Sciences (2002-2010).
Visiting Research Fellow of the Institute for International Health, Sydney, Australia (2000-2001). Post Doctoral Research Fellow of the Japan Society for the Promotion of Science (1999-2002). PhD from Tohoku University School of Medicine (1999); MD from Tohoku University School of Medicine (1993).
Faculty Member: Japan Society of Hypertension, Japan Epidemiological Association, Japanese Association for Cerebro-cardiovascular Disease Control, Japan Atherosclerosis Society, European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. Journal Editor: Hypertension (Guest Editor 2013-), Hypertension Research (Assoc. Editor 2014-).
Major Research Activities: Hypertension, Blood Pressure Monitoring, Epidemiology; Principal Investigater, the Ohasama Study; Secretary General of NIPPON DATA2010; Member of Management Committee, the HOMED-BP Study; Member of several national and international collarbarated project on hypertension and cardiovascular disease
意大利帕多瓦大学内科教授，现职：意大利帕多瓦大学Patavinum研究院高级学者
意大利米兰市Milano-Bicocca大学内科与外科系心血管内科教授，意大利米兰IRCCS Auxologico科学院意大利San Luca医院心血管神经和代谢科科学总监兼主任
意大利米兰市Milano-Bicocca大学内科与外科系心血管内科教授，意大利米兰IRCCS Auxologico科学院意大利San Luca医院心血管神经和代谢科科学总监兼主任
澳大利亚悉尼新南威尔士大学医学部大众健康系心脏、血管和代谢医学教授兼首席主题组长。澳大利亚悉尼乔治全球健康研究所心血管项目教授级研究员
澳大利亚悉尼新南威尔士大学医学部大众健康系心脏、血管和代谢医学教授兼首席主题组长。澳大利亚悉尼乔治全球健康研究所心血管项目教授级研究员
Alta (Aletta E.) is a Strategic Hires (SHARP) Professor of Cardiovascular Medicine at UNSW Sydney with a joint appointment as Professorial Fellow at The George Institute Australia. She also holds a professorial appointment at North-West University and the University of the Witwatersrand, South Africa. She was the President of the International Society of Hypertension (2018-2020), during which time she initiated the development of the 2020 ISH Global Hypertension Practice Guidelines for low and high resource settings.
She a leading researcher in hypertension and cardiovascular health, with a research interest is the early detection, prevention and effective management of hypertension, where she has led many population and clinical studies. She has been the Chief Investigator of several multidisciplinary studies investigating social, environmental and behavioural determinants of raised blood pressure, subsequent organ damage and cardiovascular disease across the life course. Alta is an invited author of the Lancet Commission on Hypertension, and of the World Health Organization’s Technical Specifications Report for Automated Non-Invasive Blood Pressure Measuring Devices 2020. Since 2017 she contributed to the establishment of the May Measurement Month global blood pressure screening campaign through the International Society of Hypertension, and she continues to contribute to the campaign as a Trustee.
She has published over 450 papers in the field, and is involved in numerous international consortia, such as the Global Burden of Disease study and the NCD Risk Factor Collaboration, World Health Organization working groups and the Lancet Commission of Hypertension. Alta is an Associate Editor of Hypertension, and editorial board member of all major hypertension journals.
医学研究教授，澳大利亚霍巴特市孟席斯医学研究所头部血压研究组副主任。
James is a clinical researcher in the field of cardiovascular disease and blood pressure. He has led national and international initiatives to improve the accuracy of blood pressure measurement, including the Australian expert consensus statement on home blood pressure monitoring and international policy statements on the validation of blood pressure measuring devices.
He has published over 300 papers in the field and collaborates widely, with roles to effect translational outcomes for many parties including the Lancet Commission on Hypertension, the World Hypertension League and the Pan American Health Organization.
英国伦敦国王学院生命科学与医学部(FoLSM)生命进程科学学院妇幼健康系产科教授、南伦敦临床研究网络临床主任
英国伦敦国王学院生命科学与医学部(FoLSM)生命进程科学学院妇幼健康系产科教授、南伦敦临床研究网络临床主任
Andrew Shennan is Professor of Obstetrics at King’s College London, based at St. Thomas’ Hospital and is Clinical Director of South London Clinical Research Network. He sits on the UK HTA commissioning board.
He specialises in clinical trials in antenatal and intrapartum care. His research interests include interventions to predict and prevent preterm birth, pre-eclampsia, global health and the use of blood pressure monitoring. He has published over 450 peer reviewed research reports (H index and RG score >50).
He has an active clinical role in managing high risk obstetric patients, including a regular hands-on labour ward commitment, and a specialist preterm birth surveillance clinic (award winning 2013/2015/2016/2019 innovations prize) that accepts national and international referrals. He is the recipient of the international 2017 Newton Prize (£200,000) for excellence in research and innovation in support of economic development and social welfare in low and middle-income countries. He was awarded an OBE in 2018 for services to maternity care.
比利时鲁汶市鲁汶大学KU Leuven心血管科学系内科学荣誉教授，高血压和心血管流行病学研究组研究协调中心主任
比利时鲁汶市鲁汶大学KU Leuven心血管科学系内科学荣誉教授，高血压和心血管流行病学研究组研究协调中心主任
Jan A. Staessen is Emeritus Professor of Medicine at the University of Leuven and former Head of Clinic at the University Hospitals Leuven, Belgium, and Emeritus Professor of Genetic Epidemiology at the Department of Epidemiology, Maastricht University, The Netherlands. He remains affiliated with the Biomedical Science Group, Faculty of Medicine, University of Leuven, Belgium. He is currently Senior Scientific Advisor to Mosaiques-Diagnostics, Hannover, Germany, the world leader in urinary proteomics, and chairs the Board of the Non-for-Profit Research Institute Alliance for the Promotion of Preventive, Medicine (url: http://www.appremed.org), Mechelen, Belgium.
希腊雅典Sotiria医院第三医学部雅典大学高血压中心STRIDE-7内科与高血压教授
Secretary, International Society of Hypertension (ISH) Council member. Immediate Past Chairman, European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and Cardiovascular Variability (2016-2022).World Hypertension League (WHL) Special Envoy for BP Measurement. International Pediatric Hypertension Association Executive Committee member. International Standardization Organization committee member on BP monitoring equipment. Elected Fellow Royal College of Physicians, Glasgow, UK. ESH ‘Peter Sleight’ Award for outstanding contribution in research, education, and leadership.
ESH Guidelines writing committee member for BP methodology; Pediatric hypertension; Hypertension Clinic set-up; BP monitors validation. Invited speaker at Hypertension Societies meetings (ESH, ISH, Australian, Belgian, Canadian, Chinese, Danish, German, Indian, Japanese, Korean, Spanish). Past President Hellenic Society of Hypertension. Chaired guidelines for hypertension management and pediatric hypertension. Founded the ‘School of Hypertension’. Assoc Editor: Hyperten Res, J Clin Hyperten. Editorial board member: 11 PubMed journals. Reviewer: 56 PubMed journals; BMJ Publishing Group, McMaster University's Health Information Research; 22 ESH and ISH meetings.
Research work focused on BP monitoring methodology and technology development and validation; pediatric hypertension; hypertension diagnosis; epidemiology; antihypertensive drug action. Authored 370 PubMed articles; Presented >350 papers; Supervised 25 MD theses. h-index 79; Citations 52,000 including citations in Hypertension Societies’ guidelines (ESH, ISH, American, British, Canadian, Australian, Japanese).
心血管内科教授
中国上海市上海交通大学医学院
Ji-Guang Wang is director of the Shanghai Institute of Hypertension, and director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
At present, he is coordinating several multicentre randomized clinical trials and population- and patient- cohort studies in China. He has published 559 full-length articles on hypertension in the international literature and 193 articles in the Chinese literature, and has lectured extensively in international and China national conferences.
He is a former Executive Council Member of the International Society of Hypertension, past president of he Asian-Pacific Society of Hypertension, past president of the Pulse of Asia Society, current deputy president of the HOPE Asia Network, and current president of the Chinese Hypertension League.
He serves on the editorial board of several international and China national journals in the field of hypertension and cardiovascular medicine as Editor-in-Chief (The Journal of Clinical Hypertension), Associate Editor (Hypertension, Hypertension Research, and so on), Section Editor or a Member.
纽约州立大学下州医学中心心血管内科部内科学教授，《The Journal of Clinical Hypertension》荣休主编
纽约州立大学下州医学中心心血管内科部内科学教授，《The Journal of Clinical Hypertension》荣休主编
Dr Michael Weber is a Professor of Medicine at Downstate College of Medicine of the State University of New York. He received his medical degree from Sydney University in Australia.
His career has focused largely on hypertension and preventive cardiology. He has been a leading part of several of the clinical trials that have helped define strategies for optimizing cardiovascular protection for patients with hypertension. He has also been very much involved with new drug development going back to the beta blockers and through to the contemporary angiotensin receptor blockers. He has also been active in recent trials of device therapy of hypertension. He was also one of the pioneers in developing ambulatory blood pressure monitoring, a technique now recommended for clinical practice by the major clinical hypertension guideline committees.
He is an author of over 500 articles in the peer-reviewed literature and has authored or edited 16 books. He was a founder of the American Society of Hypertension (ASH) and the ASH Hypertension Clinical Specialists Accreditation Program and has served as President of both those organizations. Dr. Weber maintains a strong interest in global hypertension issues and is a member of the Executive Committee of the International Society of Hypertension. He was Chair of the Writing Committee of the 2014 ASH/ISH Hypertension Clinical Practice Guidelines
He is currently Editor in Chief of the Journal of Clinical Hypertension, the official Journal of the World Hypertension League. He is a Fellow of The American College of Physicians, The American College of Cardiology and The American Heart Association. He has served on the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration and continues as a consultant to that Agency. He has also served as Chairman of the Formulary Committee of a major pharmacy benefits provider serving many of the leading health plans in the United States.
His main research interests are in clinical trials of patients at high risk of cardiovascular events or strokes. He is also participating actively in trials in patients with metabolic disorders such as diabetes and kidney disease. Dr. Weber currently serves on the Steering Committees of several national and international clinical trials.
希腊雅典雅典大学医学院内科名誉教授
希腊雅典雅典大学医学院内科名誉教授
希腊雅典Hygeia医院高血压诊所助理医师
希腊雅典Hygeia医院高血压诊所助理医师
希腊雅典Agioi Anargiroi综合肿瘤医院心脏内科主任
希腊雅典Agioi Anargiroi综合肿瘤医院心脏内科主任
牛津大学、加州大学旧金山分校和雅典大学的前学术人员。希腊雅典Hygeia综合医院心脏内科名誉主任
牛津大学、加州大学旧金山分校和雅典大学的前学术人员。希腊雅典Hygeia综合医院心脏内科名誉主任
希腊雅典雅典大学医学院内科名誉教授
希腊雅典雅典大学医学院内科名誉教授
STRIDE BP当然主席
希腊雅典大学高血压中心STRIDE-7内科与高血压教授
STRIDE BP当然主席
希腊雅典大学高血压中心STRIDE-7内科与高血压教授
Secretary, International Society of Hypertension (ISH) Council member. Immediate Past Chairman, European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and Cardiovascular Variability (2016-2022).World Hypertension League (WHL) Special Envoy for BP Measurement. International Pediatric Hypertension Association Executive Committee member. International Standardization Organization committee member on BP monitoring equipment. Elected Fellow Royal College of Physicians, Glasgow, UK. ESH ‘Peter Sleight’ Award for outstanding contribution in research, education, and leadership.
ESH Guidelines writing committee member for BP methodology; Pediatric hypertension; Hypertension Clinic set-up; BP monitors validation. Invited speaker at Hypertension Societies meetings (ESH, ISH, Australian, Belgian, Canadian, Chinese, Danish, German, Indian, Japanese, Korean, Spanish). Past President Hellenic Society of Hypertension. Chaired guidelines for hypertension management and pediatric hypertension. Founded the ‘School of Hypertension’. Assoc Editor: Hyperten Res, J Clin Hyperten. Editorial board member: 11 PubMed journals. Reviewer: 56 PubMed journals; BMJ Publishing Group, McMaster University's Health Information Research; 22 ESH and ISH meetings.
Research work focused on BP monitoring methodology and technology development and validation; pediatric hypertension; hypertension diagnosis; epidemiology; antihypertensive drug action. Authored 370 PubMed articles; Presented >350 papers; Supervised 25 MD theses. h-index 79; Citations 52,000 including citations in Hypertension Societies’ guidelines (ESH, ISH, American, British, Canadian, Australian, Japanese).